Search
for
Sort by
Research 271–300 of 1000+
- Distinct tooth regeneration systems deploy a conserved battery of genes
- Microneedle Frequency Adjunct to 2% Minoxidil in Female androgenetic alopecia: A Randomized Controlled Trial
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- 27604 Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial
- The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- 42175 PASI improvement in the first 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE guselkumab clinical trials
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Combination of light-emitting diode with minoxidil 2%, topical corticosteroid and oral immunomodulator induced hair regrowth in a pediatric alopecia areata
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors
- Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- New Synthesis of Finasteride
- 4. Bullous/Mucous Membrane
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Alopecia with Vitamin D-Dependent Rickets Type 2 A: A Case Report
- <i>Pinus thunbergii</i> bark extract rich in flavonoids promotes hair growth in dorsal skin by regulating inflammatory cytokines and increasing growth factors in mice
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- The first clinical trial of topical application of procyanidin B‐2 to investigate its potential as a hair growing agent
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Prooxidant and antioxidant action of 4-(4-phenoxybenzoyl)benzoic acid derivatives
- 2 Cases of Alopecia areata treated with Korean Medicine
- 3,4,5-Tri-O-Caffeoylquinic Acid Promoted Hair Pigmentation Through β-Catenin and Its Target Genes